Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
309 participants
INTERVENTIONAL
2020-07-05
2020-09-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
In this research, it is aimed to determine the positive and negative effects of pandemic on parents and disabled children and to provide an insight for future solutions.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
SCREENING
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Parents who have a disabled child or children
Parents having disabled child or children will be included in the research and it will be wanted to complete the survey questionary
Difficulties lived by disabled children's parents in the period of COVID-19 pandemic
It will be a cross sectional study to obtain the information on difficulties lived by disabled children's parents during recent pandemic period
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Difficulties lived by disabled children's parents in the period of COVID-19 pandemic
It will be a cross sectional study to obtain the information on difficulties lived by disabled children's parents during recent pandemic period
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Having ability and facility to use internet
* Having ability to read and write
* Having enough cognitive capacity to answer the questionnaire
* To accept to participate the research
Exclusion Criteria
* Not having ability and facility to use internet
* Not having ability to read and write
* Not having enough cognitive capacity to answer the questionnaire
* Not to accept to participate the research
18 Years
65 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Gaziosmanpasa Research and Education Hospital
OTHER_GOV
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Berrin Hüner
Medical Doctor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Resa Aydin, Professor
Role: PRINCIPAL_INVESTIGATOR
İstanbul University İstanbul Faculty of Medicine
Evrim Karadağ Saygı, Professor
Role: PRINCIPAL_INVESTIGATOR
Marmara University Faculty of Medicine
Özden Özyemisçi Taşkıran, Professor
Role: PRINCIPAL_INVESTIGATOR
Koc University Faculty of Medicine
Nalan Çapan, Professor
Role: PRINCIPAL_INVESTIGATOR
İstanbul University İstanbul Faculty of Medicine
Ebru Yilmaz Yalçınkaya, Professor
Role: STUDY_DIRECTOR
Health Science University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Health Science University Gaziosmanpasa Training and Research Hospital
Istanbul, Gaziosmanpasa, Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Ahorsu DK, Lin CY, Imani V, Saffari M, Griffiths MD, Pakpour AH. The Fear of COVID-19 Scale: Development and Initial Validation. Int J Ment Health Addict. 2022;20(3):1537-1545. doi: 10.1007/s11469-020-00270-8. Epub 2020 Mar 27.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
105
Identifier Type: -
Identifier Source: org_study_id